ADRIAMYCIN - NEW ANTICANCER DRUG WITH SIGNIFICANT CLINICAL ACTIVITY

被引：1211

作者：

BLUM, RH ^{[1
]}

CARTER, SK ^{[1
]}

机构：

[1] NCI, DIV CANC TREATMENT, BETHESDA, MD 20014 USA

来源：

关键词：

D O I：

10.7326/0003-4819-80-2-249

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：249 / 259

页数：11

共 71 条

[1]

[Anonymous], [No title captured]

[2]

Arcamone F., 1972, INT S ADRIAMYCIN, P9, DOI [10.1007/978-3-642-95227-2_2, DOI 10.1007/978-3-642-95227-2_2]

[3]

ARENA E, 1971, ARZNEI-FORSCHUNG, V21, P1258

[4]

BACHUR N, 1973, P AM ASSOC CANC RES, V14, P56

[5]

BACHUR NR, 1971, P AM ASSOC CANC RES, V12, P33

[6]

BENJAMIN RS, 1973, CANCER CHEMOTH REP 1, V57, P98

[7]

BENJAMIN RS, 1972, 14 INT C HEM SAO PAU

[8] HEXAMETHYLMELAMINE - NEW DRUG WITH ACTIVITY IN SOLID TUMORS [J].

BLUM, RH ;

LIVINGSTON, RB ;

CARTER, SK .

[9]

BLUM RH, 1973, CANCER, V31, P903, DOI 10.1002/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO

[10]

2-N